Summary
This prediction ended on 24.05.23 with a price of €42.79. The BUY prediction by Traumtanz finished with a performance of 2.79%. Traumtanz has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| QIAGEN NV | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to Traumtanz what are the pros and cons of QIAGEN NV for the foreseeable future?
Pros
Normal challenges to pay loans and raise capital
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Growths faster than the competition
Stable Large shareholder and/or long term investor
Medium risks for its business
Capable Management
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Sustainability is important
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
